DIA will host Dried Blood Spot Sampling in the Pharmaceutical Industry: Three Years Of Experience and Implementation from May 3-4, 2011 in Philadelphia, PA. Session topics include:
- Strategic Implementation of DBS Technology
- Hematocrit Effects and Impact
- Impact of Sampling Site Location
- Dried Matrix Spots and Alternative Micro-sampling Approaches
- Moving Beyond Small Molecule Quantitation and Pharmacokinetics
Special breakout sessions will explore best practices, advantages and hurdles to implementation and impact of study results.
“Sampling from dried blood spots (DBS) on specialty papers is a novel methodology in the area of pharmacokinetics and toxicokinetics that continues to be an active area of increasing interest and implementation,” says Program Chair Christopher A. Evans, PhD, Section Manager, PTS – DMPK GlaxoSmithKline. “This workshop will focus on the three areas primarily impacted by DBS implementation: bioanalytical, preclinical studies and safety assessment, and clinical studies and clinical pharmacokinetics.
DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org